Next Article in Journal
Mineralization of Early Stage Carious Lesions In Vitro—A Quantitative Approach
Next Article in Special Issue
New Direct Oral Anticoagulants (DOAC) and Their Use Today
Previous Article in Journal / Special Issue
Management of Antithrombotic Agents in Oral Surgery Maria Martinez and Dimitrios A. Tsakiris *
Article Menu

Export Article

Open AccessArticle
Dent. J. 2015, 3(4), 102-110; doi:10.3390/dj3040102

A Study of the Management of Patients Taking Novel Oral Antiplatelet or Direct Oral Anticoagulant Medication Undergoing Dental Surgery in a Rural Setting

Balfour Oral Surgery Unit, NHS Orkney, Balfour Hospital, Kirkwall, Orkney KW15 1BH, Scotland, UK
Academic Editor: Claude Jaquiéry
Received: 17 August 2015 / Revised: 21 September 2015 / Accepted: 24 September 2015 / Published: 6 October 2015
(This article belongs to the Special Issue Medically Compromised Patients in Dentistry)
View Full-Text   |   Download PDF [99 KB, uploaded 6 October 2015]

Abstract

Purpose: Novel oral antiplatelet (NOAP) (prasugrel and ticagrelor) and direct oral anticoagulant drugs (DOAC) (dabigatran, rivaroxaban and apixaban) have emerged in the last decade. This study was undertaken to determine current approaches taken to the management of patients taking these agents in dental practice in a remote and rural setting. Methods: A small retrospective study was carried out in a small island population that identified patients taking one of the above drugs. All national health service and private dental records were examined to determine the type of treatment carried out and whether drug therapy, treatment plans or actual treatment were modified as a result of NOAP or DOAC therapy. In addition other outcomes such as referral to another service for advice or treatment and any adverse bleeding events were noted. Results: 156 dental encounters for 95 patients taking one of the drugs were identified. Significant events were identified in sixteen encounters and the management of patients taking each drug type differed significantly between cases but no patients returned with troublesome post-operative bleeding. Conclusions: The approaches taken by dental surgeons in Orkney in the management of the NOAPs and DOACs varied and this is likely to be a reflection of the limited literature available. View Full-Text
Keywords: NOAP; DOAC; Target-specific Oral Anticoagulants (TSOAC); Novel Oral Anticoagulants (NOAC); prasugrel; ticagrelor; dabigatran; rivaroxaban; apixaban NOAP; DOAC; Target-specific Oral Anticoagulants (TSOAC); Novel Oral Anticoagulants (NOAC); prasugrel; ticagrelor; dabigatran; rivaroxaban; apixaban
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Johnston, S. A Study of the Management of Patients Taking Novel Oral Antiplatelet or Direct Oral Anticoagulant Medication Undergoing Dental Surgery in a Rural Setting. Dent. J. 2015, 3, 102-110.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Dent. J. EISSN 2304-6767 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top